There was a clear trend towards a reduced use of systemic glucocorticoids, which dropped from 48.6% to 5.8% during follow-up, while the administration of bDMARDs increased to 72.5%.
← all excerpts
Musculoskeletal manifestations in children with inflammatory bowel disease: a multicenter cohort study (GASTROREUM study).
1
—
—